Skip to content

Clinical trials

Phase 2 Lymphoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 2 Country / region: South Korea Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20062
20081
20091
20103
20112
20141
20163
20172
20222
20231
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting4
Unknown status4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Samsung Medical Center3
Seoul National University Hospital3
Cooperative Study Group A for Hematology2
Celgene1
Dong-A University Hospital1
GlaxoSmithKline1
Hyungwoo Cho1
Incyte Corporation1
Janssen Research & Development, LLC1
Konkuk University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma23
Multiple Myeloma4
Recurrence4
Lymphoma, Extranodal NK-T-Cell2
Lymphoma, Follicular2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Non-Hodgkin2
Amyloidosis1
Dendritic Cell Sarcoma, Interdigitating1
Hematologic Neoplasms1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.